As of January 2026, only 13 state Medicaid programs cover GLP-1 medications for the treatment of obesity under fee-for-service
In briefing documents for the meeting, the FDAs experts said there is a lack of evidence on effectiveness and safety to justify letting pharmacies make the peptides that the panel will review
Supports skin, hair, and overall cellular health at a fundamental level
They also explored the effects of taurine dose and examined secondary outcomes of taurine supplementation, including body composition, lipid profile, and blood glucose control
For example, if you wanted Ozempic, and you decided to get it from Mochi, youd pay a $79 monthly fee on top of the cost of medication
Treatment frequency follows established timelines